Pre-clinical and clinical studies were conducted at the TNO Nutrition and Food Research (The Netherlands), CERN (Centre d’Enseignement et de Recherche en Nutrition, France) and Obesity Clinic (Germany).
The results from these studies have consistently shown Liposinol™'s efficacy as a fat binder. It is clinically proven to bind up to 27.4% of dietary fats.
The recent 2-armed, randomized, double blind, placebo-controlled fat elimination study of Liposinol™ conducted in Germany has once again proven Liposinol™ as a superior fat binder, which also resulted in weight loss and increased satiation.
These promising results have shown us new angles in which to direct our research on Liposinol™. This on-going process continues as we further explore the diversified functions of Liposinol™ as a weight management tool.
Effective 1st April 2015, all goods and services may be subjected to GST 6% upon checkout.
MCIL Multimedia Sdn.Bhd.(515740-D)
Copyright ©2017,Mykris Net MSC.
All Rights Reserved.